You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 22, 2024

PHOTREXA VISCOUS IN DEXTRAN 20% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Photrexa Viscous In Dextran 20% patents expire, and what generic alternatives are available?

Photrexa Viscous In Dextran 20% is a drug marketed by Glaukos and is included in one NDA.

The generic ingredient in PHOTREXA VISCOUS IN DEXTRAN 20% is riboflavin 5'-phosphate. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate profile page.

Summary for PHOTREXA VISCOUS IN DEXTRAN 20%
Drug patent expirations by year for PHOTREXA VISCOUS IN DEXTRAN 20%
Anatomical Therapeutic Chemical (ATC) Classes for PHOTREXA VISCOUS IN DEXTRAN 20%

US Patents and Regulatory Information for PHOTREXA VISCOUS IN DEXTRAN 20%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaukos PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.